|
Wednesday 2nd March 2016 |
Text too small? |
New Zealand manuka honey company Comvita is linking up with its Australian counterpart Capilano Honey to form an apiary business in Australia.
The companies have signed a memorandum of understanding to form a jointly-owned business which would produce leptospermum honey, commonly known as manuka, for medical and natural health products, Te Puke-based Comvita said in a statement.
Comvita has sales and marketing operations in Australia and the venture with Capilano will enable it to secure greater volumes of honey to be processed in Australia to meet growing global demand. For Capilano, the venture would help it expand its specialised leptospermum apiary operation in Australia and secure greater honey supply.
"Comvita and Capilano have already been involved in a joint research initiative to investigate the medicinal properties of Australian leptospermum honey," Comvita said. "In order to best satisfy growing sales, both companies recognise the need to expand their operations and grow the supply base for premium quality honey, especially in Australia. Both businesses believe they will achieve significant long term benefits by working together."
Comvita and Capilano are benefiting from consumer demand for health and wellness products. Comvita's shares last traded at $9.20 on the NZX and have gained 122 percent over the past year, making it the third-best performer on the S&P/NZX All Capital Index. Capilano's stock last traded at A$18.65 on the ASX.
BusinessDesk.co.nz
No comments yet
VHP - Half year results announcement date and webcast details
Devon Funds Morning Note - 30 January 2026
AIA - Auckland Airport new board appointment
General Capital (GEN:NZ) Subsidiary General Finance Update
January 30th Morning Report
January 29th Morning Report
VSL - Date for 1H FY26 results announcement
January 28th Morning Report
IKE - Webinar Notification IKE Q3 FY26 Performance Update
VHP - Preliminary unaudited portfolio valuations 31 December 2025